Thursday, November 13, 2014

Best Life Sciences Stocks To Invest In Right Now

Malaysia's state-owned agri-business conglomerate FELDA is looking to tap growing demand for botanical drugs and treatments with a planned $300 million IPO (Initial Public Offering) of its life sciences unit on the Nasdaq exchange by March 2015, a press release confirmed.

Felda Wellness Corp (IPO-FWCP.O) is a unit of the Federal Land Development Authority of Malaysia (FELDA). The company had for long been thinking about going public and finally announced the listing today. It has chosen to list on the U.S. market for technology and biotech companies because of the country's well developed market for health products and U.S. investors' familiarity with such offerings, they said.

The only other Malaysian firm to have announced a Nasdaq listing is MOL Global Pte Ltd (IPO-MOLL.O), an online payment firm that also owns social networking site Friendster Inc. The company plans to raise $300 million from its U.S. IPO scheduled for this year end. Felda Wellness has been working with a New York-based investment bank with expertise in raising funds for life sciences companies in the United States. Bankers to advice on the deal will be chosen in September after the listing is approved by the FELDA board.

Top 5 Stocks To Invest In Right Now: Gentium SpA(GENT)

Gentium S.p.A., a biopharmaceutical company, focuses on the development and manufacture of its primary product candidate, defibrotide, an investigational drug based on a mixture of single-stranded and double-stranded DNA extracted from pig intestines. It develops defibrotide for the treatment and prevention of hepatic veno-occlusive disease (VOD), a condition that occurs when veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation, that are administered prior to stem cell transplantation. The company has completed a Phase III clinical trial of defibrotide for the treatment of severe VOD in the United States, Canada, and Israel; and a Phase II/III pediatric trial in Europe for the prevention of VOD. It also offers sulglicotide that is developed from swine duodenum, and has ulcer healing and gastrointestinal protective properties in South Korea; and urokinase, which is made from human urine to treat various vascular disorders, such as deep vein thrombosis and pulmonary embolisms. The company was formerly known as Pharma Research S.r.L. and changed its name to Gentium S.p.A. in July 2001. Gentium S.p.A. was founded in 1993 and is headquartered in Villa Guardia, Italy.

Advisors' Opinion:
  • [By James Oberweis]

    Gentium Spa (GENT) is focused on the development and commercialization of its leading product, defibrotide, to treat certain complications arising from chemotherapy, and bone marrow and stem cell transplantation therapy.

  • [By Sean Williams]

    A parabolic problem
    It has also been a year to remember for shareholders of biopharmaceutical company Gentium (NASDAQ: GENT  ) whose share price has catapulted approximately 600% off its lows thanks to growth in its lead drug Defibrotide (known as Defitelio in the European Union).

Best Life Sciences Stocks To Invest In Right Now: National-Oilwell Inc.(NOV)

National Oilwell Varco, Inc. designs, constructs, manufactures, and sells systems, components, and products used in oil and gas drilling and production; provides oilfield services and supplies; and distributes products, and provides supply chain integration services to the upstream oil and gas industry worldwide. Its Rig Technology segment offers offshore and onshore drilling rigs; derricks; pipe lifting, racking, rotating, and assembly systems; rig instrumentation systems; coiled tubing equipment and pressure pumping units; well workover rigs; wireline winches; wireline trucks; cranes; and turret mooring systems and other products for floating production, storage and offloading vessels, and other offshore vessels and terminals. The company?s Petroleum Services & Supplies segment provides various consumable goods and services to drill, complete, remediate, and workover oil and gas wells and service pipelines, flowlines, and other oilfield tubular goods. It also manufacture s, rents, and sells products and equipment for drilling operations, including drill pipe, wired drill pipe, transfer pumps, solids control systems, drilling motors, drilling fluids, drill bits, reamers and other downhole tools, and mud pump consumables. In addition, this segment provides oilfield tubular services comprising the provision of inspection and internal coating services; equipment for drill pipe, line pipe, tubing, casing, and pipelines; and coiled tubing pipes and composite pipes. Its Distribution Services segment sells maintenance, repair and operating supplies, and spare parts to drill site and production locations. The company primarily serves drilling contractors, shipyards and other rig fabricators, well servicing companies, pressure pumping companies, oil and gas companies, supply stores, and pipe-running service providers. National Oilwell Varco, Inc. was founded in 1862 and is based in Houston, Texas.

Advisors' Opinion:
  • [By Lauren Pollock]

    Among the companies with shares expected to actively trade in Tuesday’s session are Applied Materials Inc.(AMAT), Red Hat Inc.(RHT) and National Oilwell Varco Inc.(NOV)

  • [By Russ Fischer]

    National Oilwell Varco (NOV)

    Energy upstream sector. National Oilwell Varco, Inc. provides equipment and components for oil and gas drilling and production. Its Rig Technology segment offers offshore and onshore drilling rigs. The company is involved in virtually all products and services in support of the oil patch worldwide. NIV should be a prime beneficiary of the expansion of shale and horizontal drilling worldwide. Yield 0.8%

  • [By Paul Ausick]

    National Oilwell Varco Inc. (NYSE: NOV) had a jump of 35.8% in short interest to 8.21 million shares, or about 1.9% of the company’s float. It is scheduled to report results on Friday, and analysts are estimating EPS at $1.39 on revenues of $5.86 billion. The revenue estimate is higher than last year’s fourth-quarter actual of $5.68 billion, but the EPS estimate is below last year’s total of $1.44.

  • [By Daniel Gibbs]

    Over the past few years, there was a boom in the offshore drilling sector. Due to this, offshore drilling companies began construction on an enormous number of offshore drilling rigs. Naturally, this also led to an enormous demand for equipment for these rigs, such as that manufactured by National Oilwell Varco (NYSE: NOV  ) .

Best Life Sciences Stocks To Invest In Right Now: Canadian/Yen (HY)

Hyster-Yale Materials Handling, Inc. and its subsidiaries engage in the design, engineering, manufacture, sale, and service of a line of lift trucks and aftermarket parts worldwide. It offers components, such as frames, masts, and transmissions; and assembles lift trucks. The company markets its products primarily under the Hyster and Yale brand names to independent Hyster and Yale retail dealerships. It also sells aftermarket parts under the UNISOURCE, MULTIQUIP, and PREMIER brands to Hyster and Yale dealers for the service of competitor lift trucks. The company was incorporated in 1991 and is headquartered in Cleveland, Ohio.

Advisors' Opinion:
  • [By Dan Caplinger]

    Lift trucks aren't the sexiest business in the stock market, but for a long time, Hyster-Yale Materials Handling (NYSE: HY  ) rode the recovery in construction and manufacturing to big gains for its forklift business. Yet so far this year, Hyster-Yale stock has performed badly, as investors started to worry about the health of the global economy. After Hyster-Yale released its third-quarter results, some investors focused almost solely on the company's extremely strong results. Yet despite what Hyster-Yale said, the real question for the company remains whether the macroeconomic trends that have propelled the U.S. forward will spread across the world, or whether the sluggishness we've seen in Europe and elsewhere will eventually cause a slowdown in the U.S. as well. Let's take a closer look at how Hyster-Yale did last quarter.

  • [By Vera Yuan]

    ��ift truck manufacturer Hyster-Yale Materials Handling, Inc. (HY) declined after the company provided qualitative guidance for the remainder of 2014 that may have been viewed negatively by some investors. Revenues and pre-tax income both increased during the quarter, but after-tax net income declined as a result of a higher tax rate.

  • [By Rich Duprey]

    Heavy-equipment maker�Hyster-Yale Materials Handling� (NYSE: HY  ) announced yesterday�its second-quarter dividend of $0.25 per share for both its Class A and Class B stock.

Best Life Sciences Stocks To Invest In Right Now: Meridian Bioscience Inc.(VIVO)

Meridian Bioscience, Inc., a life science company, engages in the development, manufacture, sale, and distribution of diagnostic test kits primarily for gastrointestinal, foodborne, viral, respiratory, and parasitic infectious diseases. The company?s diagnostic products primarily consist of C. difficile for the detection of gastrointestinal diseases; Rotavirus and Adenovirus products for pediatric diarrhea detection; H. pylori for stomach ulcers; Enterohemorrhagic E. coli infection and Campylobacter jejuni used in the detection of foodborne diseases; Varicella-Zoster for viral diseases; and Cytomegalovirus for organ transplant infections. Its products also include transport media that store and preserve specimen samples from patient collection to laboratory testing. The company?s diagnostic test kits utilize immunodiagnostic and molecular technologies, which test samples of stool, blood, urine, and other body fluids or tissue for the presence of specific infectious disea ses. In addition, Meridian Bioscience, Inc. manufactures and distributes bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers and other diagnostic manufacturers. Further, it involved in the contract development and manufacture of proteins and other biologicals under cGMP conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The company sells its diagnostic test kits through direct sales force and independent distributors to reference laboratories and hospitals, principally in the United States, Canada, Belgium, France, Holland, Italy, the United Kingdom, Africa, the Middle East, and other European countries. The company was founded in 1976 and is headquartered in Cincinnati, Ohio.

Advisors' Opinion:
  • [By Marc Bastow]

    Integrated life sciences company Meridian Biosciences (VIVO) raised its quarterly dividend 5.3% to 20 cents per share, payable on Feb. 14 to shareholders of record as of Feb. 3.
    VIVO Dividend Yield: 3.22%

  • [By Seth Jayson]

    Meridian Bioscience (Nasdaq: VIVO  ) reported earnings on July 25. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended June 30 (Q3), Meridian Bioscience met expectations on revenues and beat expectations on earnings per share.

Best Life Sciences Stocks To Invest In Right Now: Hydrogenics Corp (HYGS)

Hydrogenics Corporation, incorporated on June 10, 2009, together with its subsidiaries, designs, develops and provides hydrogen generation and fuel cell products based on water electrolysis technology and proton exchange membrane (PEM) technology. The Company conducts its business through two business units: OnSite Generation, which focuses on hydrogen generation products for renewable energy, industrial and transportation customers, and Power Systems, which focuses on fuel cell products for original equipment manufacturers (OEMs) systems integrators and end users for stationary applications, including backup power, and motive applications, such as forklift trucks. The Company�� products include HySTAT hydrogen generation equipment in its OnSite Generation business and HyPM fuel cell products in its Power Systems business.

The Company maintains operations in Belgium, Canada and Germany. Its OnSite Generation business segment is based in Oevel, Belgium and develops products for industrial gas, hydrogen fueling and renewable energy storage markets. The Company�� Power Systems business segment is based in Mississauga, Canada, with a satellite facility in Gladbeck, Germany, and develops products for energy storage, stationary and motive power applications.

OnSite Generation

The Company�� OnSite Generation business segment, is based on water electrolysis technology, which includes the decomposition of water into oxygen (O2) and hydrogen gas (H2) by passing an electric current through a liquid electrolyte. Its brand includes HySTAT electrolyzer products, which is configured for both indoor and outdoor applications. Its OnSite Generation products are sold to merchant gas companies, such as Air Liquide and Linde Gas and end-users requiring hydrogen produced on-site for industrial applications. The Company also sells and services products for oil and gas companies, such as Shell Hydrogen, requiring hydrogen fueling stations for transportation applications.

Power Systems

The Company�� Power Systems business segment is based on PEM fuel cell technology, which transforms chemical energy liberated during the electrochemical reaction of hydrogen and oxygen into electrical energy. It also develops and delivers hydrogen generation products based on PEM water electrolysis, which can also be used to serve the energy storage markets. Its target markets include backup power for telecom and data centre installations and motive power applications, such as buses, trucks and utility vehicles. The Company�� Power Systems products are sold to original equipment manufacturers (OEMs), such as CommScope, Inc. (CommScope) to provide backup power applications for telecom installations and vehicle and other integrators for motive power, direct current (DC) and alternative current (AC) backup. In addition, its products are sold for prototype field tests. The Company also sells its Power Systems products to the military.

HySTAT Hydrogen Stations

HySTAT Hydrogen Stations offer an on-site supply of hydrogen for a range of hydrogen applications, including vehicle fuelling, distributed power, and a variety of industrial processes. It also provides spare parts and service for its entire installed base.

As of December 31, 2011, the Company offered its HySTAT Hydrogen Station in multiple configurations based on the amount of hydrogen required. This product is suitable for producing continuous or batch supplies of hydrogen for industrial processing applications and generates between 10 - 60 normal cubic meters per hour (Nm3/hr) of hydrogen.

HyPM Fuel Cell Products

The Company�� HyPM fuel cell products provide electrical power from clean hydrogen fuel. Its HyPM fuel cell products include HyPM Fuel Cell Power Modules, HyPX Fuel Cell Power Pack, Integrated Fuel Cell Systems and Engineering Development Services. Its HyPM power module runs on hydrogen and produces direct current (DC) power. This product! is suita! ble for a range of stationary, mobile and portable power applications. The HyPM XR model is targeted at backup power applications and the HyPMHD model is targeted at motive power applications. The Company�� HyPX Power Pack includes a HyPM power module integrated with hydrogen storage tanks and ultracapacitors that provide higher power in short bursts. Its integrated fuel cell systems are built around its HyPM power modules and used for portable and stationary applications, including portable and auxiliary power units for military applications and DC backup power system for cellular tower sites. The Company also enters into engineering development contracts with certain customers for new or custom products.

The Company competes with Air Liquide and Linde Gas.

Advisors' Opinion:
  • [By Paul Ausick]

    Peers Plug Power Inc. (NASDAQ: PLUG), Ballard Power Systems Inc. (NASDAQ: BLDP), and Hydrogenics Corp. (NASDAQ: HYGS) have also shared in the stock price run-up. Any investor expecting more from FuelCell�� results was, perhaps, being irrationally exuberant.

Best Life Sciences Stocks To Invest In Right Now: Consolidated Communications Holdings Inc.(CNSL)

Consolidated Communications Holdings, Inc., together with its subsidiaries, provides telecommunications services to residential and business customers in Illinois, Texas, and Pennsylvania. Its telecommunications services include local and long-distance services, high-speed broadband Internet access, standard and high-definition digital television, digital telephone services, custom calling features, private line services, carrier access services, network capacity services over its regional fiber optic network, and competitive local exchange carrier (CLEC) services. The company also offers telephone directory publishing services, wholesale transport services on its fiber-optic network in Texas, billing and collection services, inside wiring services, and maintenance services. In addition, it provides automated calling services for correctional facilities; and sells and supports telecommunications equipment, such as key, private branch exchange, and IP-based telephone system s to business customers in Texas and Illinois. The company serves residential customers, and universities and hospitals, as well as retail, commercial, light manufacturing, and service industry accounts in Illinois; manufacturing and retail industries, hospitals, local governments, and school districts in Texas; and small to mid-sized businesses, educational institutions, and healthcare facilities in Pennsylvania. As of December 31, 2011, it had 227,992 local access lines, 110,913 digital subscriber lines, 34,356 Internet protocol digital television subscribers, 9,199 voice over Internet protocol, and 89,774 CLEC access line equivalents. The company was founded in 1894 and is headquartered in Mattoon, Illinois.

Advisors' Opinion:
  • [By David Dittman]

    Answer: I�� leery of the rural telecoms right now. I do recommend Consolidated Communications Holdings Inc (NSDQ: CNSL) in the UF Income Portfolio, but it benefits from a JV with Verizon Communications Inc (NYSE: VZ) that generates substantial cash flow and sets it apart from its peers, who are otherwise struggling against declines in traditional wireline businesses as well as intense competition from bigger, better-funded national players in broadband and business service.

No comments:

Post a Comment